Rocket Doctor AI

Rocket Doctor AI Current Assets

Delisted

The Current Assets of Rocket Doctor AI (TRUE.CN) as of Nov 16, 2026 is 1.28 M CAD. In the previous year, Current Assets was 739,300.00 CAD — a change of 73.03% (higher).

Current Assets

1.28 MCAD

YoY

73.03%

Last updated:

Current Assets of Rocket Doctor AI is 2024 1.28 M CAD. Current Assets of Rocket Doctor AI was 2023 739,300.00 CAD. It decreases by 73.03% higher compared to the previous year.

The Rocket Doctor AI Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
11,000.00 CAD
Jan 1, 2018
25,200.00 CAD
Jan 1, 2019
515,400.00 CAD
Jan 1, 2020
312,600.00 CAD
Jan 1, 2021
942,600.00 CAD
Jan 1, 2022
13,600.00 CAD
Jan 1, 2023
739,300.00 CAD
Jan 1, 2024
1.28 M CAD
The Rocket Doctor AI Current Assets history
YEARCurrent AssetsYoY
1.28 MCAD+73.03%
739,300.00CAD+5,336.03%
13,600.00CAD-98.56%
942,600.00CAD+201.54%
312,600.00CAD-39.35%
515,400.00CAD+1,945.24%
25,200.00CAD+129.09%
11,000.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Rocket Doctor AI Stock analysis

What does Rocket Doctor AI do? Treatment.com AI Inc generates revenue through its Treatment Digital Health App, a symptom assessment tool developed by a global team of doctors and engineers. The app provides predictive health insights using disease rate estimates, geographic variation data, and medical research, targeting patients and caregivers seeking informed health decisions. The company also offers medical education solutions and clinical advisor services, serving healthcare professionals and institutions globally. Revenue streams include subscriptions for app access and tailored medical education programs. The Treatment Digital Health App is designed for widespread use, offering advanced medical knowledge access to users worldwide. Medical clinic solutions are integrated into the platform, supporting healthcare providers in decision-making. Clinical advisor services leverage the AI platform to assist clinics and institutions with specialized medical guidance. These offerings are marketed to healthcare consumers, clinics, and educational institutions as part of the company's global healthcare technology strategy. Treatment.com AI Inc's business model focuses on AI-driven health solutions, with the Treatment Digital Health App as its primary product. The app's predictive health assessments are updated regularly by medical professionals, ensuring relevance and accuracy. The company monetizes through direct consumer subscriptions and B2B partnerships with medical clinics and educational providers, emphasizing global accessibility and evidence-based medical insights. Rocket Doctor AI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rocket Doctor AI stock

Current Assets of Rocket Doctor AI is 1.28 M CAD in 2024.

Current Assets of Rocket Doctor AI changed from 739,300.00 CAD to 1.28 M CAD, representing a 73.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Rocket Doctor AI since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Rocket Doctor AI historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Rocket Doctor AI

All Key Metrics — Rocket Doctor AI